| 注册
首页|期刊导航|中国医药科学|他克莫司治疗慢性炎性脱髓鞘性多发性神经根神经病患者的临床效果

他克莫司治疗慢性炎性脱髓鞘性多发性神经根神经病患者的临床效果

郝小军

中国医药科学2024,Vol.14Issue(10):90-94,5.
中国医药科学2024,Vol.14Issue(10):90-94,5.DOI:10.20116/j.issn2095-0616.2024.10.22

他克莫司治疗慢性炎性脱髓鞘性多发性神经根神经病患者的临床效果

Clinical efficacy of tacrolimus in the treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy

郝小军1

作者信息

  • 1. 内蒙古自治区鄂尔多斯市中心医院神经内科,内蒙古鄂尔多斯 017000
  • 折叠

摘要

Abstract

Objective To explore the effect of tacrolimus on the severity of illness,activity of daily living,and clinical outcomes of patients with chronic inflammatory demyelinating polyradiculoneuropathy(CIDP).Methods A random number table method was used to divide 40 patients with CIDP admitted to Ordos Central Hospital in Inner Mongolia from January 2018 to August 2021 into the control group and the study group,with 20 cases in each group.The control group received first-line induction therapy combined with prednisone treatment,while the study group received first-line induction therapy combined with tacrolimus treatment.The clinical symptom relief time,limb motor function,neurological function,activity of daily living,severity of illness,adverse reactions,liver and kidney function indicators,and clinical outcomes of the two groups were compared.Results The relief time of sensory disorders,limb weakness,limb pain,and abnormal tendon reflex between the two group was compared,without statistically significant difference(P>0.05).After the treatment,the scores of the Medical Research Council(MRC)muscle strength assessment grading scale and Barthel index(BI)assessment scale in both groups were higher than those before the treatment,while the American Spinal Injury Association(ASIA)neurological function score was lower than that before the treatment,with statistically significant difference(P<0.05).The MRC muscle strength assessment scale grading,BI assessment scale,and ASIA neurological function score after the treatment were compared between the two groups,without statistically significant differences(P>0.05).The degree of improvement of illness was compared between the two groups,without statistically significant difference(P>0.05).The incidence of adverse reactions,liver and kidney function indicators,recurrence rate,and mortality rate were compared between the two groups,without statistically significant differences(P>0.05).Conclusion The clinical efficacy of tacrolimus is comparable to that of prednisone,and it can alleviate clinical symptoms,and improve limb motor function,neurological function,and activity of daily living in a short period,with high safety.

关键词

慢性炎性脱髓鞘性多发性神经根神经病/他克莫司/神经功能/日常生活能力/临床结局

Key words

Chronic inflammatory demyelinating polyradiculoneuropathy/Tacrolimus/Neurological function/Activity of daily living/Clinical outcomes

分类

医药卫生

引用本文复制引用

郝小军..他克莫司治疗慢性炎性脱髓鞘性多发性神经根神经病患者的临床效果[J].中国医药科学,2024,14(10):90-94,5.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文